During the past decade, Klinikum Kemperhof Koblenz conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinikum Kemperhof Koblenz" are "Neuroblastoma" (2 trials), "Brain and Central Nervous System Tumors" (1 trials), "Leukemia" (1 trials), "Long-term Effects Secondary to Cancer Therapy in Children" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Klinikum Kemperhof Koblenz" in a lesser frequency.

Most popular intervention types in "Klinikum Kemperhof Koblenz" are "Radiation" (5 trials), "Drug" (4 trials), "Procedure" (4 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ifosfamide" (4 trials), "radiation therapy" (4 trials), "vindesine" (4 trials), "autologous hematopoietic stem cell transplantation" (3 trials) and "carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Kemperhof Koblenz" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Kemperhof Koblenz". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Klinikum Kemperhof Koblenz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Kemperhof Koblenz, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".